Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
CRISPR Therapeutics
HiFiBiO Therapeutics
Incyte Corporation
Actym Therapeutics, Inc.
M.D. Anderson Cancer Center
Merck Sharp & Dohme LLC
Travera Inc
Nurix Therapeutics, Inc.
Incyte Corporation
Incyte Corporation
Telix Pharmaceuticals (Innovations) Pty Limited
Medicenna Therapeutics, Inc.
Cancer Research UK
Turnstone Biologics, Corp.